首页> Antimicrobial Agents and Chemotherapy> Molecular mechanism of hepatitis C virus replicon variants with reduced susceptibility to a benzofuran inhibitor, HCV-796.

Molecular mechanism of hepatitis C virus replicon variants with reduced susceptibility to a benzofuran inhibitor, HCV-796.

导出原文传递

翻译打印收藏纠错

第一作者： Howe AY

作者： Howe AY ^[1] ; Cheng H ; Johann S ; Mullen S ; Chunduru SK ; Young DC ; Bard J ; Chopra R ; Krishnamurthy G ; Mansour T ; O'Connell J

作者单位： Antivral Discovery, Wyeth Research, 500 Arcola Road, Collegeville, Pennsylvania 19426, USA. ahowe@its.jnj.com ^[1]

关键词 Hepatitis C virus Replicon RNA Cancer resistance to treatment benzofuran 复制子

发布时间 2013-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览1

Antimicrobial Agents and Chemotherapy

2008年52卷9期

3327-3338页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览1

Antimicrobial Agents and Chemotherapy

2008年52卷9期

3327-3338页

检索历史清除

Molecular mechanism of hepatitis C virus replicon variants with reduced susceptibility to a benzofuran inhibitor, HCV-796.

Antimicrobial Agents and Chemotherapy

相似文献

同项目论文

Antimicrobial Agents and Chemotherapy

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Molecular mechanism of hepatitis C virus replicon variants with reduced susceptibility to a benzofuran inhibitor, HCV-796.

Antimicrobial Agents and Chemotherapy

相似文献

同项目论文

Antimicrobial Agents and Chemotherapy

相关期刊

检索历史清除